News Daily News Revascularization Decisions in the Elderly Require a Holistic Approach: AHA Caitlin E. Cox November 24, 2025
News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Daily News PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI L.A. McKeown November 04, 2025
News Conference News TCT 2025 INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time Michael O'Riordan October 29, 2025
News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS Todd Neale October 03, 2025
News Daily News CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI Michael O'Riordan September 23, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits Michael O'Riordan July 14, 2025
News Daily News Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION Michael O'Riordan June 04, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization Yael L. Maxwell April 07, 2025
News Daily News High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada Michael O'Riordan February 10, 2025
News Daily News Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab Michael O'Riordan February 05, 2025
News Conference News AHA 2024 Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360 Michael O'Riordan November 18, 2024